0001209191-19-060662.txt : 20191216 0001209191-19-060662.hdr.sgml : 20191216 20191216163501 ACCESSION NUMBER: 0001209191-19-060662 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191213 FILED AS OF DATE: 20191216 DATE AS OF CHANGE: 20191216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yanni Barbara CENTRAL INDEX KEY: 0001610561 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 191287576 MAIL ADDRESS: STREET 1: 1018 W. 8TH AVENUE STREET 2: SUITE A CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-13 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001610561 Yanni Barbara C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 1 0 0 0 Stock Option (right to buy) 19.30 2019-12-13 4 A 0 53000 0.00 A 2029-12-12 Common Stock 53000 53000 D The shares vest over a four year period in equal annual installments beginning on December 13, 2019. /s/ Joshua F. Patterson, Attorney-in-Fact 2019-12-16